Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be ...

New York and Hong Kong, April 12, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced that ...

Most cancers are caused by a large variety of factors that vary from one person to another. To unravel this complexity, genes that contribute to the development of a respective cancer must be ...

The transcription factor HIF1A is a key mediator of the cellular response to hypoxia. Despite the importance of HIF1A in homeostasis and various pathologies, little is known about how it regulates RNA ...

To view these abstracts, please visit the American Society of Hematology website located at http://www.hematology.org/Annual-Meeting/Abstracts. Ryvu Therapeutics is a ...

Based on the structure and binding mode of existent molecules, Insilico’s R&D team used Chemistry42, the small molecule generation and design platform integrating more than 40 generative models, to ...

Many cancers depend on glucose consumption for energy, but good pharmacological targets to stop cancers' ability to uptake and metabolize glucose are missing. A new study finally identifies a way to ...

The gene CDK8, which was believed to be harmless, has now been proved to be linked to colon cancer. The research was conducted by the Dana-Farber Cancer Institute, Boston, USA. The scientists ...

A team of researchers led by the University of Colorado Boulder has discovered a protein complex that could be targeted with drugs to stunt tumor growth. As tumors expand, their centers are deprived ...

Abu Dhabi, April 24, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company which operates the largest ...